Innovative Medical Device Company Reflexion Counts On Medrio To Launch First Studies

In launching their initial clinical studies, RefleXion, an emerging therapeutic oncology company working to develop novel solutions for cancer treatment, searched for a partner that offered both the technology needed to run complex oncology programs, as well as the ability to identify and solve problems quickly.

“Starting out, we needed a partner that could help us build our database but also had the ability to stick with us over the course of our trials and help with updates and enhancements,” said Didem Aksoy, Senior Director of Clinical Affairs at RefleXion. “We looked at a number of potential partners but were impressed with Medrio’s professionalism and felt that they truly understood our mission.”

Learn how RefleXion was able to get set up with a robust Electronic Data Capture (EDC) system, establish a platform for collecting electronic patient-reported outcome assessments (ePRO), and provide process guidance for provisioning data collection devices to sites and patients.